About
Black Hawk Acquisition Corporation (NASDAQ:BKHA) — investor relations, events, news, and company updates on 6ix.
Latest News
Jul 8 2025
Black Hawk Acquisition Corporation Amends Its Definitive Proxy Statement
Apr 28 2025
Vesicor Therapeutics, Inc. and Black Hawk Acquisition Corporation Enter into a Business Combination Agreement to Create a Biotechnology Company Advancing p53-based Cancer Therapeutics Delivered Via Microvesicles
Financials
Revenue
$0
Market Cap
$48.14 M
P/E Ratio
61.00
EPS
0.19
Translate